Literature DB >> 18333061

Hepatic resection for benign non-cystic liver lesions.

D L Clarke1, E J Currie, K K Madhavan, R W Parks, O J Garden.   

Abstract

BACKGROUND: Hepatic resection is indicated for a variety of benign conditions because of persistent symptoms, uncertainty regarding the diagnosis or the risk of malignant transformation. The aim of this study was to assess the indications for and outcome of hepatic resection for benign non-cystic liver lesions in a specialist hepatobiliary unit. PATIENTS AND METHODS: All patients who had undergone hepatic resection for benign non-cystic hepatic lesions between 1989 and 2001 were identified from a prospective database for analysis.
RESULTS: A total of 49 patients (40 women, 9 men) with a mean age of 43 years (range 21-75 years) underwent resection of non-cystic benign lesions. Indications for operation included suspected liver cell adenoma (n=11), suspicion of malignancy (11), persistent symptoms attributable to the lesion (20) or chronic sepsis (7). The final diagnosis was focal nodular hyperplasia (n=12), haemangioma (12), adenoma (8), sclerosing cholangitis (5), inflammatory pseudotumour (4), intrahepatic cholelithiasis (3), chronic hepatic abscess (3), benign biliary fibrosis (I) and leiomyoma (I). Major anatomical hepatic resections were performed in 44 patients, and 5 patients underwent a segmentectomy or minor atypical resection. Median operating time was 215 min (range 45-450 min) and median blood loss was 875 ml (range 200-4000 ml). Ten patients (20%) required a median blood transfusion of 2 units (range 2-8 units). The median postoperative stay was 10 days (range 4-33 days). There were no deaths, but complications occurred in 15 patients (27%).
CONCLUSIONS: Hepatic resection can be safely recommended for selected patients with a variety of benign non-cystic hepatic lesions. A small group of patients undergo resection as a result of inability to rule out a malignant process, but the large majority will be operated on because of either their malignant potential or related symptoms.

Entities:  

Year:  2004        PMID: 18333061      PMCID: PMC2020664          DOI: 10.1080/13651820410026326

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  20 in total

1.  Pyogenic hepatic abscess. Changing trends over 42 years.

Authors:  C J Huang; H A Pitt; P A Lipsett; F A Osterman; K D Lillemoe; J L Cameron; G D Zuidema
Journal:  Ann Surg       Date:  1996-05       Impact factor: 12.969

2.  Benign and malignant tumors of the liver--introduction.

Authors:  H Bismuth
Journal:  World J Surg       Date:  1995 Jan-Feb       Impact factor: 3.352

3.  Excisional therapy for benign hepatic lesions.

Authors:  S Iwatsuki; S Todo; T E Starzl
Journal:  Surg Gynecol Obstet       Date:  1990-09

4.  Changing management of pyogenic liver abscess.

Authors:  R Rintoul; M G O'Riordain; I F Laurenson; J L Crosbie; P L Allan; O J Garden
Journal:  Br J Surg       Date:  1996-09       Impact factor: 6.939

5.  Incidence of benign pathology in patients undergoing hepatic resection for suspected malignancy.

Authors:  R A E Clayton; D L Clarke; E J Currie; K K Madhavan; R W Parks; O J Garden
Journal:  Surgeon       Date:  2003-02       Impact factor: 2.392

6.  Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features.

Authors:  P Kerlin; G L Davis; D B McGill; L H Weiland; M A Adson; P F Sheedy
Journal:  Gastroenterology       Date:  1983-05       Impact factor: 22.682

7.  Benign liver tumors: differential diagnosis and indications for surgery.

Authors:  A Weimann; B Ringe; J Klempnauer; P Lamesch; K F Gratz; M Prokop; H Maschek; G Tusch; R Pichlmayr
Journal:  World J Surg       Date:  1997 Nov-Dec       Impact factor: 3.352

8.  Resection of presumed benign liver tumours.

Authors:  J Belghiti; D Pateron; Y Panis; V Vilgrain; J F Fléjou; J P Benhamou; F Fékété
Journal:  Br J Surg       Date:  1993-03       Impact factor: 6.939

Review 9.  Inflammatory pseudotumour of the liver with malignant transformation. Report of two cases.

Authors:  C Zavaglia; M Barberis; F Gelosa; G Cimino; E Minola; L Mondazzi; R Bottelli; G Ideo
Journal:  Ital J Gastroenterol       Date:  1996-04

Review 10.  Needle track seeding of primary and secondary liver carcinoma after percutaneous liver biopsy.

Authors:  T G John; O J Garden
Journal:  HPB Surg       Date:  1993
View more
  9 in total

Review 1.  Focal nodular hyperplasia: a review of current indications for and outcomes of hepatic resection.

Authors:  Alex P Navarro; Dhanwant Gomez; Christopher M Lamb; Adam Brooks; Iain C Cameron
Journal:  HPB (Oxford)       Date:  2013-10-15       Impact factor: 3.647

Review 2.  Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases.

Authors:  Jan H M B Stoot; Robert J S Coelen; Mechteld C De Jong; Cornelis H C Dejong
Journal:  HPB (Oxford)       Date:  2010-10       Impact factor: 3.647

3.  Transarterial embolization with bleomycin for symptomatic hepatic focal nodular hyperplasia.

Authors:  Guodong Zhang; Maoqiang Wang; Feng Duan; Kai Yuan; Kai Li; Jieyu Yan; Zhongfei Chang
Journal:  Diagn Interv Radiol       Date:  2017 Jan-Feb       Impact factor: 2.630

4.  National trends in the use of surgery for benign hepatic tumors in the United States.

Authors:  Yuhree Kim; Neda Amini; Jin He; Georgios A Margonis; Matthew Weiss; Christopher L Wolfgang; Martin Makary; Kenzo Hirose; Gaya Spolverato; Timothy M Pawlik
Journal:  Surgery       Date:  2015-03-11       Impact factor: 3.982

Review 5.  Solitary Fibrous Tumor of the Liver: a Review of the Current Knowledge and Report of a New Case.

Authors:  Marcelo A Beltrán
Journal:  J Gastrointest Cancer       Date:  2015-12

6.  Bile duct leaks from the intrahepatic biliary tree: a review of its etiology, incidence, and management.

Authors:  Sorabh Kapoor; Samiran Nundy
Journal:  HPB Surg       Date:  2012-05-08

7.  Solitary necrotic nodule of the liver mimicking hepatocellular carcinoma: a case report.

Authors:  Spiros G Delis; Dionysia A Kelgiorgi; Anastasios A Sofianidis; Charikleia C Triantopoulou; Ioannis A Papailiou; Christos G Dervenis
Journal:  Cases J       Date:  2009-01-25

8.  Sclerosing haemangiomas of the liver: two cases of mistaken identity.

Authors:  C Lauder; G Garcea; H Kanhere; G J Maddern
Journal:  HPB Surg       Date:  2009-12-29

9.  RF Ablation of Giant Hemangiomas Inducing Acute Renal Failure: A Report of Two Cases.

Authors:  Aukje A J M van Tilborg; Helena F Dresselaars; Hester J Scheffer; Karin Nielsen; Colin Sietses; Petrousjka M van den Tol; Martijn R Meijerink
Journal:  Cardiovasc Intervent Radiol       Date:  2016-07-07       Impact factor: 2.740

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.